Europe Hair Loss Treatment Products - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The europe hair loss treatment products market size was valued at USD 0.84 billion in 2025 and estimated to grow from USD 0.9 billion in 2026 to reach USD 1.23 billion by 2031, at a CAGR of 6.62% during the forecast period (2026-2031). This report is Segmented by Product Type (Shampoos and Conditioners, Serums, Others), Gender (Male, Female), Category (Topical, Oral), Distribution Channel (Supermarkets/Hypermarkets, Health and Beauty Stores, Online Retail Stores, Other Distribution Channels), and Geography (Germany, United Kingdom, Spain, Italy and More). The Market Forecasts are Provided in Terms of Value (USD).

Europe Hair Loss Treatment Products Market Trends and Insights

High prevalence of male pattern baldness and increasing hair loss issues

Male pattern hair loss (MPHL), also known as male androgenetic alopecia, is a highly heritable and age-dependent condition affecting a large proportion of men in Europe. According to a 2023 report by the National Institute of Health, hair loss in European men can begin as early as puberty, with a lifetime prevalence estimated to be approximately 80%. The condition is characterized by a progressive and distinct pattern of hair thinning and loss, typically starting with recession at the temples and thinning at the crown, eventually leading to baldness on the top of the scalp. This progressive hair loss has significant psychological and social effects, impacting self-esteem, confidence, and overall quality of life. The genetic basis of MPHL is strong, with androgen hormones playing a central role in follicular miniaturization and hair cycle disruption. Given its high prevalence and profound emotional impact, MPHL continues to be a key driver of demand for hair loss treatment products in Europe, encouraging innovation and the adoption of a range of therapeutic options.

Growing awareness and concern about personal appearance and grooming

Consumers in Europe are increasingly prioritizing convenience and protective benefits when purchasing wellness and beauty products. A 2023 survey conducted by Professional Beauty revealed that UK consumers, on average, spend GBP 4,600 annually on wellness-related products. This substantial expenditure reflects a growing commitment to self-care and grooming, as consumers actively seek high-quality, effective, and convenient solutions to enhance their personal appearance and overall well-being. They are not only investing in products that deliver visible results but are also showing a preference for brands that align with their values, such as sustainability and ethical sourcing. The beauty and personal care sector continues to demonstrate robust growth and resilience, playing a significant role in strengthening the regional economy and driving advancements in treatments and product innovations. This ongoing trend highlights the market's shift towards premiumization, with consumers increasingly demanding scientifically advanced formulations that cater to their evolving needs and expectations.

High cost of hair loss treatment products limiting consumer affordability

The high cost of hair loss treatment products is a significant restraint on consumer affordability within the Europe Hair Loss Treatment Products Market. Premium products, including clinically approved topical treatments, oral medications, and advanced therapies such as platelet-rich plasma (PRP) and stem cell treatments, often carry price points that can be prohibitive for many consumers. For example, hair transplant procedures in Europe can range from approximately ERU 2,850 to EUR 12,000 depending on the clinic and treatment scope, while ongoing topical and oral treatments frequently require consistent investment over time. These costs, combined with limited insurance coverage for cosmetic treatments, restrict market accessibility, particularly among lower-income consumer segments. Additionally, the availability of alternative treatment methods such as surgery or laser therapy introduces competitive pressure, complicating purchasing decisions. Consequently, high pricing remains a considerable challenge that manufacturers and marketers must address to expand the user base and fully tap into the European market potential.

Other drivers and restraints analyzed in the detailed report include:

• Rising demand for natural and organic hair loss treatment products
• High incidence of age-related hair thinning due to an aging population
• Side effects and allergies associated with certain chemical-based products

Segment Analysis

Shampoos and conditioners held the dominant position in the Europe hair loss treatment products market in 2025, capturing a significant 83.55% share. Their strong presence is largely attributed to their established role as everyday essentials in personal grooming routines, offering convenience and familiarity to a wide base of consumers. These formats are perceived as easy-to-use, low-effort solutions that can be seamlessly integrated into existing hair care habits without requiring additional time or learning. This inherent accessibility continues to appeal to both new and existing consumers, reinforcing their popularity across diverse demographic segments. Moreover, shampoos and conditioners are widely available across retail channels, ranging from supermarkets to specialty stores, further supporting their leadership in this market. Their dominance also reflects consumer trust in tried-and-tested product forms, which are often the first line of defense when addressing hair loss concerns.

In contrast, serums represent the fastest-growing segment, projected to expand at a CAGR of 6.92% through 2031. Unlike traditional daily-use formats, serums are positioned as specialized treatments that deliver a higher concentration of active ingredients directly to the scalp or hair roots. This targeted approach resonates strongly with consumers seeking effective and visible solutions for hair thinning and loss, especially amid rising awareness of advanced treatment options. Their association with premiumization has further elevated the segment, as many serums are marketed with advanced formulations and clinically backed efficacy claims. Additionally, the growth of e-commerce and direct-to-consumer channels has made serums more accessible, enabling brands to highlight their value proposition to niche yet growing consumer groups. As personal care moves toward a focus on results-driven and customized solutions, serums are set to gain momentum as a preferred choice for consumers demanding more targeted outcomes.

Female consumers commanded the largest share of the Europe hair loss treatment products market in 2025, accounting for 68.74% of the total. This dominance stems from the higher level of awareness among women regarding hair care and the greater emphasis placed on personal appearance and grooming. Women are more likely to seek proactive solutions to manage hair thinning or loss, making them the primary target group for a wide range of treatment products. Additionally, marketing strategies across brands often focus heavily on female consumers, reinforcing both visibility and adoption rates within this segment. The availability of diverse product formats, from shampoos and conditioners to advanced serums, further supports their engagement with the category. As a result, the female segment maintains its leading position, sustained by strong demand arising from lifestyle-driven concerns and ongoing self-care trends.

On the other hand, male consumers represent the fastest-growing segment, projected to expand at a CAGR of 6.85% between 2025 and 2031. This growth highlights a significant shift in treatment acceptance patterns among men, who are increasingly open to adopting preventive and corrective solutions for hair loss. Social changes and the reduced stigma around male grooming and self-care are key factors fueling this trend. Furthermore, the rising demand for targeted solutions, such as hair growth serums and scalp therapies designed specifically for men, has accelerated interest within this segment. The influence of digital platforms and direct-to-consumer marketing has also played a vital role in normalizing treatment options for male consumers, encouraging broader adoption. Consequently, the male demographic is evolving into a critical growth driver for the market, reshaping long-term demand dynamics within the hair loss treatment landscape.

Complete Report Scope:

• By Product Type
  • Shampoos and Conditioners
  • Serums
  • Others
• By Gender
  • Male
  • Female
• By Category
  • Topical
  • Oral
• By Distribution Channel
  • Supermarkets/Hypermarkets
  • Health and Beauty Stores
  • Online Retail Stores
  • Other Distribution Channels
• By Geography
  • Germany
  • United Kingdom
  • Italy
  • France
  • Spain
  • Netherlands
  • Poland
  • Belgium
  • Sweden
  • Rest of Europe

List of Companies Covered in this Report:

• Procter & Gamble Company
• L'Oréal SA
• Henkel AG & Co. KGaA
• Natura & Co.
• Unilever PLC
• Dr. Wolff Group
• Himalaya Wellness Co.
• TRESemmé
• Clariant Natural Ingredients
• Scandinavian Biolabs
• Kenvue, Inc.
• Merck & Co., Inc.
• Cipla Ltd.
• Sun Pharmaceutical Industries
• Pfizer Inc.
• Eli Lilly and Company
• Incyte Corporation
• Fagron N.V.
• Alma Lasers
• Theradome Inc.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support